IMD International Medical Devices SpA
IMD International Medical Devices SpA designs, develops, and commercializes advanced medical equipment and technology, primarily serving the healthcare services and equipment sector.
Business. IMD International Medical Devices SpA (IMD.MI) is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is headquartered in Italy and is listed on the Borsa Italiana. Specific details regarding its operating segments and geographic revenue mix are not provided.
Analyst recommendations
1 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
IMD International Medical Devices SpA (IMD.MI) is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is headquartered in Italy and is listed on the Borsa Italiana. Specific details regarding its operating segments and geographic revenue mix are not provided.
IMD's capital structure is characterized by a lack of dilution risk, as shares outstanding remain unchanged between basic and diluted counts at 17,321,175. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Profitability and returns data are not available in the current valuation snapshot, and no industry_config preferred metrics are provided for comparison. This limits the ability to assess IMD's performance relative to its peers in the Advanced Medical Equipment & Technology industry.
IMD's revenue concentration and geographic exposure are not disclosed in the available data. The company does not provide segment-level revenue breakdowns or geographic distribution details, making it difficult to evaluate diversification or concentration risk.
Growth trajectory is not quantified in the outlook, as no numeric deltas or revenue history are provided. Analysts have issued a single "Hold" recommendation with no strong buy or buy ratings, and the mean price target is 1.75 EUR.
Risk factors include the inability to assess liquidity risk and the absence of disclosed dilution sources. No recent filings or transcripts are available to provide insight into management commentary or strategic direction.
Recent events, including filings or transcripts, are not available in the source documents, limiting the ability to assess IMD's current strategic or operational developments.
- IMD operates in the Advanced Medical Equipment & Technology industry with a high classification confidence of 0.92.
- The company shows no dilution risk, as basic and diluted shares outstanding are equal.
- Analysts have issued a single "Hold" recommendation with a mean price target of 1.75 EUR.
- IMD lacks disclosed segment or geographic revenue data, limiting visibility into diversification.
- Liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue €34.3M, −12,9% YoY; Operating income −46,4% YoY.
- ▍Revenue €34.3M, −12,9% YoY
- ▍Operating income −46,4% YoY
- ▍Net income −37,3% YoY
- ▍Free cash flow −116,5% YoY
- ▍Net margin 4.1%
Revenue €39.3M, +3,5% YoY; Operating income −15,6% YoY.
- ▍Revenue €39.3M, +3,5% YoY
- ▍Operating income −15,6% YoY
- ▍Net income +0,6% YoY
- ▍Free cash flow −10,8% YoY
- ▍Net margin 5.7%
Revenue €38.0M, −9,1% YoY; Operating income −28,5% YoY.
- ▍Revenue €38.0M, −9,1% YoY
- ▍Operating income −28,5% YoY
- ▍Net income −24,4% YoY
- ▍Free cash flow −57,4% YoY
- ▍Net margin 5.8%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,09 |
| Revenue | —no estimate | —no estimate | 35,5M EUR |
| Operating income | —no estimate | —no estimate | 2,2M EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- IMD International Medical Devices SpA Market data — financials · 2026-05-28
- IMD International Medical Devices SpA Market data — analyst estimates · 2026-05-28